Talaris Therapeutics
Louisville, US · Delaware corporation · 10 known investors
Find your way into Talaris Therapeutics
Sign up to see every warm intro you have to Talaris Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Talaris Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Clinical-stage biotech developing cell therapy products for transplant and autoimmune conditions
Founders & leadership

Board
Investors · 10
How we know: Aisling Capital's portfolio page · Not right? Tell us
How we know: Keyhorse Capital's portfolio page · Not right? Tell us
How we know: Longitude Capital's portfolio page · biospace.com · Not right? Tell us
How we know: Qiming Venture Partners USA's portfolio page · biospace.com · Not right? Tell us
How we know: Viking Global's portfolio page · Not right? Tell us
How we know: biospace.com · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$115M disclosed across 1 of 2 rounds · 2019–2020
- Undisclosed amountSeries AApr 2019
Blackstone Life Sciences (lead), Longitude Capital, Qiming Venture Partners USA
Source ↗
▶$115MraisedOct 2020 · 24 investors · BiotechnologyRule 506(b)
- Sandip AgarwalaDirector
- Scott RequadtExecutive Officer, Director
- Geoff MackayDirector
- Francois NaderDirector
- Mark McDadeDirector
- Nick GalakatosDirector
- Suzanne IldstadExecutive Officer, Director
- Offering amount
- $115M
- Amount sold
- $115M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Talaris Therapeutics do?
- Clinical-stage biotech developing cell therapy products for transplant and autoimmune conditions
- Who founded Talaris Therapeutics?
- Talaris Therapeutics was founded by Suzanne Ildstad.
- Who are Talaris Therapeutics's investors?
- Talaris Therapeutics's investors include Aisling Capital, Keyhorse Capital, Longitude Capital, Qiming Venture Partners USA, Viking Global, Blackstone Life Sciences, Citadel, Invus and 2 more.
- How much funding has Talaris Therapeutics raised?
- Talaris Therapeutics has disclosed $115M raised across 1 of its 2 known rounds.
- Where is Talaris Therapeutics headquartered?
- Talaris Therapeutics is headquartered in Louisville, US.





